Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Stenting for Unprotected and Protected Left Main Stem Disease: A Comparison of Short‐ and Long‐term Outcome

Stenting for Unprotected and Protected Left Main Stem Disease: A Comparison of Short‐ and... Left main coronary artery (LMCA) stenosis is usually treated with coronary artery bypass surgery. However, in high risk surgical patients, coronary stenting may be advantageous. We reviewed the records of all 16 patients who had undergone this procedure in our institution. Group I (nine patients, eight males, mean age 64.6 years) had protected LMCA disease. Group II (seven patients, six males, mean age 69.5 years) had unprotected LMCA disease. Procedural success was achieved in 15 patients. Outcome was divided into short‐term (in hospital), and long‐term events. The mean follow‐up for both groups was 16.9 months and 9 months respectively. Three patients died (two in group II). Three patients had repeat revascularization procedure (group I). Six patients were asymptomatic (two in group I), and four had a significant improvement in angina symptoms. LMCA stenting is a relatively safe and effective revascularization procedure for patients with either protected or unprotected LMCA disease at high risk for surgery. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Interventional Cardiology Wiley

Stenting for Unprotected and Protected Left Main Stem Disease: A Comparison of Short‐ and Long‐term Outcome

Loading next page...
 
/lp/wiley/stenting-for-unprotected-and-protected-left-main-stem-disease-a-XNDZrLfK3P

References (25)

Publisher
Wiley
Copyright
Copyright © 1997 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0896-4327
eISSN
1540-8183
DOI
10.1111/j.1540-8183.1997.tb00064.x
Publisher site
See Article on Publisher Site

Abstract

Left main coronary artery (LMCA) stenosis is usually treated with coronary artery bypass surgery. However, in high risk surgical patients, coronary stenting may be advantageous. We reviewed the records of all 16 patients who had undergone this procedure in our institution. Group I (nine patients, eight males, mean age 64.6 years) had protected LMCA disease. Group II (seven patients, six males, mean age 69.5 years) had unprotected LMCA disease. Procedural success was achieved in 15 patients. Outcome was divided into short‐term (in hospital), and long‐term events. The mean follow‐up for both groups was 16.9 months and 9 months respectively. Three patients died (two in group II). Three patients had repeat revascularization procedure (group I). Six patients were asymptomatic (two in group I), and four had a significant improvement in angina symptoms. LMCA stenting is a relatively safe and effective revascularization procedure for patients with either protected or unprotected LMCA disease at high risk for surgery.

Journal

Journal of Interventional CardiologyWiley

Published: Dec 1, 1997

There are no references for this article.